2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia

BACKGROUND: Outcomes are improved with ceftazidime–avibactam (CZA) compared with polymyxin-based regimens (PBR) for carbapenemase-producing carbapenem-resistant Enterobacteriaceae. It is unclear whether this finding is true in non-carbapenemase (non-CP) producing CRE. The purpose of this study was t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Borjan, Jovan, Shelburne, Samuel A, Bhatti, Micah M, Aitken, Samuel L
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811329/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1924
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker